Makes precision injection-molded plastic components — drug-delivery devices, FMCG packaging and consumer products — in India.
Makes precision injection-molded plastic components — drug-delivery devices, FMCG packaging and consumer products — in India.
Makes molded parts to its customers' own designs under multi-year programmes, so a pen or inhaler component qualified for a drug maker's product tends to be made by the same supplier for years. Its growth in pharma devices comes from drug makers outsourcing the manufacture of injectable pen devices.
Moat: narrow (process know-how, customer qualification). Precision molding qualification for pharma devices is technical, but global device makers like Gerresheimer are far larger.
Headquarters: Vadodara, India · Founded: 1994 · Employees: 3,202
Size Shaily Engineering Plastics (SHAILY.NS) is an India Materials company (Chemicals: Specialty) with a market value of $1.53B, the 468th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹3,101 on 18 Nov 2026.
Performance Over six months the shares gained 17.6%, against -30.1% for the median peer and +3.8% for the India market (cap-weighted) — 2nd highest of 20 in its peer set.
Growth Revenue grew 18.4% over the last twelve months (peer median +12.7%); the operating margin is 23.7% (peer median 7.7%).
Valuation It trades at 57.7× forward earnings against a peer median of 14.0× (2nd most expensive of 16).
Price implies For today's price to make sense, revenue must grow about 36% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is +14 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 8.6 points above its cost of capital (11.3% WACC).
Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹10.9B | ₹9.87B | ₹7.84B | ₹6.44B | ₹6.07B |
| Revenue growth | — | +26% | +22% | +6% | — |
| Gross profit | ₹4.25B | ₹3.05B | ₹1.76B | ₹1.20B | ₹862M |
| EBITDA | ₹3.12B | ₹2.78B | ₹1.75B | ₹1.19B | ₹968M |
| Net income | ₹1.87B | ₹1.70B | ₹931M | ₹573M | ₹351M |
| Free cash flow | n/a | ₹321M | ₹259M | -₹92.6M | -₹181M |
| Capital expenditure | n/a | ₹1.86B | ₹722M | ₹951M | ₹1.12B |
| Total debt | ₹1.80B | ₹1.77B | ₹1.88B | ₹2.09B | ₹1.87B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Shaily Engineering Plastics SHAILY.NS | $1.53B | +18% | +18% | 24% | 57.7× | 36.4% |
| Gerresheimer GXI.DE | $1.26B | +21% | +9% | -4% | 16.0× | 57.0% |
| West Pharmaceutical Services WST | $28.1B | +32% | +13% | 23% | 40.2× | 25.8% |
| Nolato NOLA-B.ST | $1.40B | +3% | 0% | 10% | 19.5× | 4.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | SHAILY.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -0.1% | -13.1% | 2nd highest of 21 |
| 6-month return | +17.6% | -30.1% | 2nd highest of 20 |
| Distance from 52-week high | -14.2% | -45.3% | 2nd highest of 21 |
| Revenue growth (TTM) | +18.4% | +12.7% | 7th highest of 20 |
| Operating margin | 23.7% | 7.7% | highest of 21 |
| Forward P/E | 57.7× | 14.0× | 2nd most expensive of 16 |
| Growth the price implies (Req g, 7 yrs) | 36.4% | 11.4% | 2nd most demanding of 13 |
| Growth delivered (Del g) | +22.8% | +4.3% | highest of 13 |
| Hurdle (Req g minus delivered) | +13.6 pp | +5.4 pp | 4th most demanding of 13 |
| ROIC minus cost of capital | +8.6 pp | -1.4 pp | highest of 21 |
| EV / EBITDA | 46.2× | 6.9× | most expensive of 10 |
| Net debt / EBITDA | 0.4× | 1.3× | 4th least indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shaily Engineering Plastics SHAILY.NS | India | $1.53B | +18% | +18% | 24% | 57.7× | 36.4% | +22.8% |
| Proto Labs PRLB | United States | $1.53B | -10% | +12% | 8% | 26.7× | 26.6% | +4.2% |
| Genesis Energy, L.P GEL | United States | $1.54B | -23% | -2% | 18% | n/a | 3.1% | -2.2% |
| Standard Nuclear STDN | United States | $1.50B | n/a | n/a | -288% | n/a | n/a | n/a |
| Stepan SCL | United States | $1.50B | +30% | +10% | 4% | 20.5× | 16.9% | +4.5% |
| Ningbo Yunsheng 600366.SS | China | $1.50B | -30% | +33% | 6% | 17.7× | 17.5% | +17.9% |
| Denka 4061.T | Japan | $1.50B | -27% | 0% | 10% | 13.2× | n/a | n/a |
| Fujian Kuncai Material Technology 603826.SS | China | $1.50B | -56% | +59% | 5% | 55.8× | 22.8% | +11.0% |
| Jiangsu Lopal Tech 603906.SS | China | $1.56B | -51% | +96% | 7% | 12.6× | n/a | n/a |
| Huabao Technology 300741.SZ | China | $1.49B | +4% | +17% | 1% | n/a | 42.0% | -8.5% |
| Jiangyin Jianghua Micro-electronics Materials 603078.SS | China | $1.49B | -19% | +18% | 7% | 83.1× | 34.6% | +17.0% |
| Osaka Soda 4046.T | Japan | $1.58B | +3% | +13% | 19% | 14.0× | 6.0% | +0.5% |
| Verbio VBK.DE | Germany | $1.58B | -42% | +19% | 8% | 13.0× | -10.2% | +12.8% |
| Chambal Fertilisers & Chemicals CHAMBLFERT.NS | India | $1.59B | -18% | +6% | 12% | 7.4× | n/a | n/a |
| Tokuyama 4043.T | Japan | $1.59B | -23% | +7% | 9% | 5.9× | 1.3% | +2.9% |
| KumhoPetrochem 011780.KS | South Korea | $1.60B | -36% | +6% | 5% | 5.9× | -13.3% | +7.5% |
| Shida Shinghwa Advanced Material 603026.SS | China | $1.46B | -58% | +58% | 8% | 6.5× | n/a | n/a |
| ADAMA 000553.SZ | China | $1.46B | -36% | -6% | 3% | 28.9× | -7.7% | +0.3% |
| LOTTE CHEMICAL 011170.KS | South Korea | $1.46B | -51% | +11% | -3% | n/a | n/a | n/a |
| Tangshan SunFar Silicon Industries 603938.SS | China | $1.61B | -30% | +30% | 8% | 40.1× | n/a | n/a |
| Shenzhen Rongda Photosensitive & Technology 300576.SZ | China | $1.44B | -39% | +14% | 10% | n/a | n/a | n/a |